The second edition of the 'Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand' is now available for use.
Download the Quality Statements – second edition
Current version: Effective from October 2022
Learn more about the 2nd edition of the Quality Statements through our six-part webinar series.
More information on this webinar series can be found here.
The 'Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand' have been developed by the National Melanoma Working Group (NMWG) with support from MelNet and Te Aho o Te Kahu, the Cancer Control Agency, and are endorsed by more than ten professional bodies.
The statements describe what quality care for melanoma should look like in New Zealand based on current global best practice and will inform efforts to reduce the incidence and improve outcomes for melanoma patients and their families.
The document is an evolution of the Standards of Service Provision for Melanoma Patients in New Zealand – Provisional which were drafted by the National Melanoma Tumour Standards Working Group for the Ministry of Health in 2013.
The 'Quality Statements' were formally launched at the New Zealand Melanoma Summit held virtually on 12 - 13 February 2022. The document was then reviewed in July 2022, with the second edition released in October 2022. This second edition builds on the previous version, integrating additional sector feedback and incorporating new research and updates to best practice. Key changes to clinical content are noted in Appendix 5 of the document.
The next formal review will be in 2023, however feedback is welcome at any time to the MelNet Chief Executive.
If you are interested in being part of the National Melanoma Working Group responsible for reviewing and updating the 'Quality Statements', please advise the MelNet Chief Executive.
Versions
Second edition: Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand Current version: Effective from October 2022
First edition: Quality Statements to Guide Melanoma Diagnosis and Treatment in New Zealand Effective from November 2021 – September 2022
